Overview of Scabies in Children

Scabies is a contagious parasitic skin infestation caused by the Sarcoptes scabiei mite and represents a significant public health concern affecting children worldwide, particularly those in crowded living conditions or institutional settings. The disease affects approximately 100-300 million people globally, with higher prevalence in developing countries and among socioeconomically disadvantaged populations. Scabies spreads through prolonged skin-to-skin contact with infested individuals and can cause epidemic spread in settings such as childcare facilities and schools. The condition is characterized by intense pruritus, often worse at night, due to the immune response to mite antigens rather than direct physical irritation. Understanding the clinical presentation, transmission patterns, and effective treatment options helps healthcare providers diagnose and treat scabies promptly, preventing spread and complications from secondary bacterial infection.

Parasite Biology and Transmission

Scabies is caused by Sarcoptes scabiei var. hominis, a microscopic mite approximately 0.4 mm in length. The female mite burrows into the stratum corneum, creating tunnels where she deposits eggs and feces. Eggs hatch in 3-5 days, and nymphs mature into adults over 10-14 days. The entire life cycle from egg to adult spans approximately 14-21 days. Adult mites live approximately 4-6 weeks on the host. Transmission occurs through prolonged skin-to-skin contact with infested individuals. Transmission through contaminated bedding or fomites occurs but is less common, as mites cannot survive more than 2-3 days off the human host. Scabies is highly contagious, with transmission rates approaching 50% in household contacts of infested individuals. The incubation period for development of symptoms (sensitization to mite antigens) is 4-6 weeks in initial infection. Subsequent re-exposure causes rapid development of symptoms within 24-48 hours due to prior sensitization.

Clinical Presentation in Children

Scabies in children presents with intense pruritus, often worse at night and in warm environments such as under bedclothes. The primary lesions are thin, linear, or S-shaped burrows in the stratum corneum, typically 5-15 mm in length, appearing as fine lines or tracks on the skin. Burrows are most commonly found in areas of thinner epidermis including the web spaces of the fingers, wrists, palms, axillae, buttocks, genitals, and feet. In children, lesions commonly involve the head, neck, and trunk, unlike in adults where these areas are often spared. Papules, pustules, and nodules frequently accompany burrows as the immune response develops. Secondary bacterial infection from intense scratching is common in children, presenting as impetigo or cellulitis. Crusted scabies (Norwegian scabies) represents a severe form occurring in immunocompromised individuals, with minimal pruritus but massive numbers of mites and thick, crusted hyperkeratotic plaques. Most affected children have 5-15 mites at a time; immunocompromised patients with crusted scabies may have thousands or millions of mites.

Diagnosis and Confirmation

Diagnosis of scabies is primarily clinical based on the clinical presentation and history of contact with infected individuals. Confirmation can be obtained through dermoscopy or microscopic examination. Using a mineral oil preparation, a burrow can be scraped and viewed under low microscopy for identification of mites, eggs, or mite feces. A positive scraping confirms diagnosis but absence does not exclude it, as mites are relatively sparse. Dermoscopy may show characteristic mite (burrow) patterns with the "mite in situ" appearance (triangular mite head with posterior body). Ink-test utilizing ink application followed by alcohol removal may highlight burrows. Biopsy showing mites in histologic sections confirms diagnosis. However, clinical diagnosis based on characteristic presentation is sufficient for most cases, and diagnosis should not be delayed awaiting confirmation if clinical suspicion is high and contact exposure is documented.

Treatment of Scabies Infestation

Permethrin 5% cream represents first-line treatment for scabies in children. The medication is applied from the neck down to the entire body surface, left on for 8-14 hours (typically overnight), then washed off. Two applications 7-14 days apart are recommended. Ivermectin oral solution has become increasingly utilized for scabies treatment and offers advantages of ease of administration, though cost and limited availability in some areas restrict its use. Ivermectin dosing is weight-based, with repeat dosing after 7-14 days. Sulfur ointment 5-10% is a safe alternative for infants under 2 months of age and pregnant women, though it is messy and less cosmetically acceptable. Crotamiton 10% cream is less effective than permethrin and not recommended as monotherapy. Treatment should be applied to the entire body including under fingernails, between toes, and in skin folds. All household members and close contacts should be evaluated and treated concurrently. Bedding, clothing, and towels should be machine washed in hot water and dried in hot dryer.

Prevention and Management of Contacts

Close contacts of affected children should be evaluated and treated prophylactically even if asymptomatic, as the incubation period may precede symptom development. Childcare and school settings with identified scabies should alert other parents and staff to watch for symptoms. Infected children can return to childcare or school 24 hours after initiating treatment, as mites are significantly reduced at that time. Household fomites should be decontaminated, though this is less critical than in lice infestation given the brief mite survival off the host. Pruritus may persist for 2-4 weeks after successful mite eradication due to continued immune response to mite antigens. Symptomatic treatment with topical corticosteroids or systemic antihistamines may help control itching during this period. Secondary bacterial infection should be treated with appropriate antibiotics. Patients and contacts should be rechecked at 2 weeks post-treatment to confirm cure, as treatment failure occasionally occurs.

Frequently Asked Questions

How does my child get scabies? Scabies spreads through prolonged skin-to-skin contact with infested individuals. Transmission through bedding is possible but less common.

Is this dangerous? Scabies itself is not life-threatening but causes intense pruritus and social embarrassment. Secondary bacterial infection can develop from scratching.

Will treatment cure the itch? The mites are killed by treatment but pruritus may persist 2-4 weeks due to ongoing immune response to mite antigens.

When can my child return to school? Children can return 24 hours after initiating appropriate treatment once most mites are eliminated.

How do we prevent re-infection? Ensuring all household and close contacts are treated concurrently prevents re-infection from untreated carriers.

References

  1. Paller AS, Mancini AJ. Hurwitz Clinical Pediatric Dermatology. 5th ed. Elsevier; 2016.
  2. Habif TP. Clinical Dermatology: A Color Guide to Diagnosis and Therapy. 6th ed. Elsevier; 2016.
  3. Currie BJ, McCarthy JS. Permethrin and ivermectin-resistant scabies in institutional settings - time for a drug like moxidectin? PLoS Negl Trop Dis. 2010;4(7):e741.
  4. Goldust M, Rezaee E, Raghifar R, et al. Scabies: epidemiology, clinical aspects, and therapeutic update. Dermatol Ther. 2016;6(1):15-23.
  5. Anderson J, Coates M. Scabies. Dermatol Clin. 2009;27(2):133-141.
  6. Chosidow O. Scabies. N Engl J Med. 2006;354(16):1718-1727.
  7. Walton SF, Currie BJ. Problems in diagnosing scabies, a global disease in human and animal populations. Clin Microbiol Rev. 2007;20(2):268-279.
  8. Augustin M, Reich K, Blome C, et al. Nail psoriasis in dermatological practice: Consensus paper on diagnosis and treatment. J Eur Acad Dermatol Venereol. 2015;29(Suppl 2):1-8.